2006 Molecular Therapeutics of Cancer Gordon Research Conference

2006年癌症分子治疗戈登研究会议

• 批准号: 7161956
• 负责人: ALAN R EASTMAN
• 金额: $ 0.5万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-08-01 至 2009-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7161956
• 关键词: meeting /conference /symposium; molecular biology; neoplasm /cancer therapy; travel

DESCRIPTION (provided by applicant): This Gordon Research Conference on Molecular Therapeutics of Cancer, held annually since 1978 (initially under the name of Chemotherapy of Experimental and Clinical Cancer), provides a highly interactive forum for the presentation and discussion of novel drugs, drug targets and the preclinical and clinical development of novel therapeutics. Meeting participants represent a diverse range of interests, spanning the pharmaceutical industry, biotechnology companies, and clinical and academic institutions. The meeting seeks to promote advancements in the treatment of human cancer through the presentation of novel, unpublished work, and to focus on the ways these advancements can be brought to the service of patient care. The informality of the meeting venue, coupled with the GRC tradition of lively and extensive discussions, provides a unique opportunity for interactions between individuals from academia, industry and the clinical arena. The 2006 meeting will continue the trend of addressing new ideas, questions and solutions at the forefront of cancer therapy focusing on targets and strategies that have yet to be presented at larger national and international meetings. Topics will include: targeting the lipogenic pathways in tumors; cell cycle checkpoint regulation; targeting therapy to BRCA1/2 defective tumors; developmental gene regulation (Hedgehog, Wnt, Notch); impact of stem cells on therapeutic response; solving problems in gene and siRNA delivery; protein phosphatases as therapeutic targets, molecular prognosis, and novel therapeutic technologies (nanotechnology and imaging).

描述（由申请人提供）：自 1978 年以来每年举行一次关于癌症分子治疗的戈登研究会议（最初以实验和临床癌症化疗的名义），为展示和讨论新药、新药、新药提供了一个高度互动的论坛。目标以及新疗法的临床前和临床开发。 会议参与者代表了不同领域的利益，涵盖制药行业、生物技术公司以及临床和学术机构。 会议旨在通过展示新颖的、未发表的工作来促进人类癌症治疗的进步，并重点关注如何将这些进步应用于患者护理服务。 会议场地的非正式性，加上 GRC 活跃而广泛讨论的传统，为来自学术界、工业界和临床领域的个人之间的互动提供了独特的机会。 2006 年会议将延续讨论癌症治疗前沿的新想法、问题和解决方案的趋势，重点关注尚未在大型国内和国际会议上提出的目标和策略。 主题包括：针对肿瘤中的脂肪生成途径；细胞周期检查点调节；针对 BRCA1/2 缺陷肿瘤的靶向治疗；发育基因调控（Hedgehog、Wnt、Notch）；干细胞对治疗反应的影响；解决基因和 siRNA 递送中的问题；蛋白磷酸酶作为治疗靶点、分子预后和新型治疗技术（纳米技术和成像）。